Avient (AVNT)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-09
$41.90-1.67%
Close 2026-09-09 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-09
Intact: The reason to own it still holds.
Avient grew adjusted EPS 9% in Q1 2026 to $0.83. The company aims for full year EPS near $3.05. Profit margins improved to 17.7% in Q1. Free cash flow is expected above $200 million in 2026.
Raw material supply issues could hurt costs and margins. Soft guidance shows some uncertainty. A CFO departure may disrupt financial leadership.
The price is about 1% below our fair value near $39. Analysts expect 4.6% revenue growth, which is factored into the price.
Breaks if: Adjusted EPS falls below $2.93 or above $3.17 in FY26
Avient aims to maintain its full year adjusted EPS guidance of $2.93 to $3.17.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable growth opportunity with a focus on improving fundamentals. The current thesis is intact, backed by recent earnings beats and management's commitment to growth and cost control.
The market appears to price AVNT as fairly valued compared to peers, reflecting a low expectations gap. However, the company's execution quality remains fragile, indicating that any missteps could lead to significant negative reactions.
Fundamentals are likely to improve as management is on track to increase earnings guidance and drive productivity. Recent financial performance has been strong, but there is a moderate risk of missing expectations given the company's history.
The thesis hinges on management's ability to maintain guidance and deliver on productivity improvements. Additionally, external factors such as inflation trends and performance of sector peers will be crucial for AVNT's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Free cash flow falls below $200 million in FY26
Breaks if: Adjusted EBITDA margin falls below 17.5%
Management emphasizes productivity improvements and disciplined cost control to expand adjusted EBITDA margins and support earnings growth.
Stated as a priority in 3 of last 3 quarters. Adjusted EBITDA margins expanded from 15.5% in 2025-Q4 to 17.7% in 2026-Q1 and further to 18.3% in 2026-Q2, reflecting management's focus on productivity and cost control. The trajectory is delivering with margin expansion.
“Delivered profitable growth and adjusted EBITDA margin expansion by 110 basis points to a record high 18.3%.”
“Strong execution on driving productivity improvement and disciplined cost control, enabling adjusted EBITDA margin expansion by 20 basis points to 17.7%.”
“Focus on driving profitable mix and productivity helped expand adjusted EBITDA margins by 80 basis points to 15.5%.”
Overall, AVNT presents a stable long-term thesis, but investors should remain cautious of potential guidance cuts and market conditions. Not investment advice.